title: Short report: ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents.
authors.affiliation: Parke-Davis Pharmaceutical Research Division of Warner-Lambert Company, Inc., Ann Arbor, MI 48105.
authors.forename: D A
authors.initials: DA
authors.lastname: Canter
authors.forename: M J
authors.initials: MJ
authors.lastname: Texter
authors.forename: R W
authors.initials: RW
authors.lastname: McLain
mesh_terms: D000553:Ambulatory Care; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D001795:Blood Pressure Determination / Q000379:methods*; D003971:Diastole; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use; D010560:Personnel Selection; D010919:Placebos; D000077583:Quinapril; D016032:Randomized Controlled Trials as Topic; D013599:Systole; D044005:Tetrahydroisoquinolines
chemical_list: D000959:Antihypertensive Agents; D007546:Isoquinolines; D010919:Placebos; D044005:Tetrahydroisoquinolines; D000077583:Quinapril